Stocks and Investing Stocks and Investing
Fri, July 21, 2023

Paul Choi Maintained (VIR) at Strong Buy with Decreased Target to $28 on, Jul 21st, 2023


Published on 2024-10-28 05:01:10 - WOPRAI, Paul Choi
  Print publication without navigation


Paul Choi of Goldman Sachs, Maintained "Vir Biotechnology, Inc." (VIR) at Strong Buy with Decreased Target from $51 to $28 on, Jul 21st, 2023.

Paul has made no other calls on VIR in the last 4 months.



There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, 0 agree with Paul's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Paul


  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $22 on, Thursday, July 20th, 2023
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $100 on, Thursday, July 20th, 2023

Contributing Sources